Regulation of AKT Activity by Inhibition of the Pleckstrin Homology Domain-PtdIns(3,4,5)P3 Interaction Using Flavonoids
2018
Kang, Y., Konkuk University, Seoul, Republic of Korea | Jang, G., Seoul National University, Seoul, Republic of Korea | Ahn, S., Konkuk University, Seoul, Republic of Korea | Lee, Y., Konkuk University, Seoul, Republic of Korea | Shin, S.Y., Konkuk University, Seoul, Republic of Korea | Yoon, Y., Konkuk University, Seoul, Republic of Korea
The serine-threonine kinase AKT plays a pivotal role in tumor progression and is frequently overactivated in cancer cells; this protein is therefore a critical therapeutic target for cancer intervention. We aimed to identify small molecule inhibitors of the pleckstrin homology (PH) domain of AKT to disrupt binding of phosphatidylinositol-3,4,5-trisphosphate (PIP3), thereby downregulating AKT activity. Liposome pulldown assays coupled with fluorescence spectrometry were used to screen flavonoids for inhibition of the AKT PH-PIP3 interaction. Western blotting was used to determine the effects of the inhibitors on AKT activation in cancer cells, and in silico docking was used for structural analysis and optimization of inhibitor structure. Several flavonoids showing up to 50% inhibition of the AKT PH-PIP3 interaction decreased the level of AKT activation at the cellular level. In addition, the modified flavonoid showed increased inhibitory effects and the approach would be applied to develop anticancer drug candidates. In this study, we provide a rationale for targeting the lipidbinding domain of AKT, rather than the catalytic kinase domain, in anticancer drug development.
显示更多 [+] 显示较少 [-]